167 related articles for article (PubMed ID: 37822396)
1. TWEAK Progress in Dermatology: A Review.
Kharel P; Jia C; Dhital KR; Chapagain P; Aryal S
Indian J Dermatol; 2023; 68(4):425-429. PubMed ID: 37822396
[TBL] [Abstract][Full Text] [Related]
2. Role of the TWEAK/Fn14 pathway in autoimmune diseases.
Xu WD; Zhao Y; Liu Y
Immunol Res; 2016 Feb; 64(1):44-50. PubMed ID: 26659091
[TBL] [Abstract][Full Text] [Related]
3. TWEAK/Fn14 Activation Participates in Skin Inflammation.
Liu Q; Xiao S; Xia Y
Mediators Inflamm; 2017; 2017():6746870. PubMed ID: 29038621
[TBL] [Abstract][Full Text] [Related]
4. Experimental atopic dermatitis is dependent on the TWEAK/Fn14 signaling pathway.
Liu Q; Wang H; Wang X; Lu M; Tan X; Peng L; Tan F; Xiao T; Xiao S; Xia Y
Clin Exp Immunol; 2020 Jan; 199(1):56-67. PubMed ID: 31515807
[TBL] [Abstract][Full Text] [Related]
5. TWEAK/Fn14 activation induces keratinocyte proliferation under psoriatic inflammation.
Cheng H; Xu M; Liu X; Zou X; Zhan N; Xia Y
Exp Dermatol; 2016 Jan; 25(1):32-7. PubMed ID: 26264384
[TBL] [Abstract][Full Text] [Related]
6. The TNF-like weak inducer of the apoptosis/fibroblast growth factor-inducible molecule 14 axis mediates histamine and platelet-activating factor-induced subcutaneous vascular leakage and anaphylactic shock.
Mendez-Barbero N; Yuste-Montalvo A; Nuñez-Borque E; Jensen BM; Gutiérrez-Muñoz C; Tome-Amat J; Garrido-Arandia M; Díaz-Perales A; Ballesteros-Martinez C; Laguna JJ; Beitia JM; Poulsen LK; Cuesta-Herranz J; Blanco-Colio LM; Esteban V
J Allergy Clin Immunol; 2020 Feb; 145(2):583-596.e6. PubMed ID: 31679818
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of cytokine TWEAK and its receptor Fn14 in pig (Sus scrofa).
Shui Y; Guan ZB; Zhang SQ
Vet Immunol Immunopathol; 2008 Dec; 126(3-4):396-402. PubMed ID: 18817982
[TBL] [Abstract][Full Text] [Related]
8. Tumor Necrosis Factor Receptor Mediates Fibroblast Growth Factor-Inducible 14 Signaling.
Wang X; Xiao S; Xia Y
Cell Physiol Biochem; 2017; 43(2):579-588. PubMed ID: 28934756
[TBL] [Abstract][Full Text] [Related]
9. Role of tumor necrosis factor-like weak inducer of apoptosis (TWEAK)/fibroblast growth factor-inducible 14 (Fn14) axis in rheumatic diseases.
Zhu LX; Zhang HH; Mei YF; Zhao YP; Zhang ZY
Chin Med J (Engl); 2012 Nov; 125(21):3898-904. PubMed ID: 23106895
[TBL] [Abstract][Full Text] [Related]
10. Fn14 deficiency ameliorates psoriasis-like skin disease in a murine model.
Peng L; Li Q; Wang H; Wu J; Li C; Liu Y; Liu J; Xia L; Xia Y
Cell Death Dis; 2018 Jul; 9(8):801. PubMed ID: 30038329
[TBL] [Abstract][Full Text] [Related]
11. The TWEAK-Fn14 system as a potential drug target.
Wajant H
Br J Pharmacol; 2013 Oct; 170(4):748-64. PubMed ID: 23957828
[TBL] [Abstract][Full Text] [Related]
12. TWEAK/Fn14 axis is an important player in fibrosis.
Zhang Y; Zeng W; Xia Y
J Cell Physiol; 2021 May; 236(5):3304-3316. PubMed ID: 33000480
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 are expressed in urticarial vasculitis.
Li M; Chen T; Guo Z; Li J; Cao N
J Dermatol; 2013 Nov; 40(11):891-5. PubMed ID: 23968277
[TBL] [Abstract][Full Text] [Related]
14. A Bioinformatics Resource for TWEAK-Fn14 Signaling Pathway.
Bhattacharjee M; Raju R; Radhakrishnan A; Nanjappa V; Muthusamy B; Singh K; Kuppusamy D; Lingala BT; Pan A; Mathur PP; Harsha HC; Prasad TS; Atkins GJ; Pandey A; Chatterjee A
J Signal Transduct; 2012; 2012():376470. PubMed ID: 22649723
[TBL] [Abstract][Full Text] [Related]
15. Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK)/Fibroblast Growth Factor-Inducible 14 (Fn14) Axis in Cardiovascular Diseases: Progress and Challenges.
Méndez-Barbero N; Gutiérrez-Muñoz C; Blázquez-Serra R; Martín-Ventura JL; Blanco-Colio LM
Cells; 2020 Feb; 9(2):. PubMed ID: 32053869
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor-inducible 14 (Fn14) is expressed in the lower genital tract and may play a role in amplifying inflammation during infection.
Han ES; Mekasha S; Ingalls RR
J Reprod Immunol; 2010 Jan; 84(1):16-23. PubMed ID: 19963275
[TBL] [Abstract][Full Text] [Related]
17. TWEAK/Fn14 signaling in tumors.
Hu G; Zeng W; Xia Y
Tumour Biol; 2017 Jun; 39(6):1010428317714624. PubMed ID: 28639899
[TBL] [Abstract][Full Text] [Related]
18. Role of the tumour necrosis factor-like weak inducer of apoptosis (TWEAK)/fibroblast growth factor-inducible 14 (Fn14) axis in autoimmune thyroid disease.
Peng S; Yu X; Zhao X; Wang X; Sun X; Han C; Shan Z; Li C; Teng W
Clin Endocrinol (Oxf); 2017 Dec; 87(6):783-790. PubMed ID: 28636775
[TBL] [Abstract][Full Text] [Related]
19. Structural basis and targeting of the interaction between fibroblast growth factor-inducible 14 and tumor necrosis factor-like weak inducer of apoptosis.
Dhruv H; Loftus JC; Narang P; Petit JL; Fameree M; Burton J; Tchegho G; Chow D; Yin H; Al-Abed Y; Berens ME; Tran NL; Meurice N
J Biol Chem; 2013 Nov; 288(45):32261-32276. PubMed ID: 24056367
[TBL] [Abstract][Full Text] [Related]
20. A further TWEAK to multiple sclerosis pathophysiology.
Nazeri A; Heydarpour P; Sadaghiani S; Sahraian MA; Burkly LC; Bar-Or A
Mol Neurobiol; 2014 Feb; 49(1):78-87. PubMed ID: 23873135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
